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Background and purpose — Polymerase chain reaction (PCR) 
methods enable detection and species identification of many 
pathogens. We assessed the efficacy of a new PCR and microar-
ray-based platform for detection of bacteria in prosthetic joint 
infections (PJIs).
Methods — This prospective study involved 61 suspected PJIs 
in hip and knee prostheses and 20 negative controls. 142 samples 
were analyzed by Prove-it Bone and Joint assay. The laboratory 
staff conducting the Prove-it analysis were not aware of the results 
of microbiological culture and clinical findings. The results of the 
analysis were compared with diagnosis of PJIs defined according 
to the Musculoskeletal Infection Society (MSIS) criteria and with 
the results of microbiological culture.
Results — 38 of 61 suspected PJIs met the definition of PJI 
according to the MSIS criteria. Of the 38 patients, the PCR 
detected bacteria in 31 whereas bacterial culture was positive in 
28 patients. 15 of the PJI patients were undergoing antimicro-
bial treatment as the samples for analysis were obtained. When 
antimicrobial treatment had lasted 4 days or more, PCR detected 
bacteria in 6 of the 9 patients, but positive cultures were noted 
in only 2 of the 9 patients. All PCR results for the controls were 
negative. Of the 61 suspected PJIs, there were false-positive PCR 
results in 6 cases.
Interpretation — The Prove-it assay was helpful in PJI diagnos-
tics during ongoing antimicrobial treatment. Without preceding 
treatment with antimicrobials, PCR and microarray-based assay 
did not appear to give any additional information over culture.  

Of the patients with a total hip or knee arthroplasty, 1–2% 
suffer from a prosthetic joint infection (PJI) (Blom et al. 2004, 
Kurtz et al. 2012). Diagnosis of a PJI is often a challenge. To 
successfully cure a PJI, an exact microbiological diagnosis is 
crucial. All the contemporary investigation methods have their 
own strengths and weaknesses.
Polymerase chain reaction (PCR) can be faster than the time-
consuming traditional culture of bacteria. The novel Prove-it 
Bone and Joint assay can provide results in 6 hours, including 
the time required for sample preparation. The Prove-it PCR 
and microarray-based platform, targeted for over 60 bacterial 
species, has proven to be faster in identifying bacterial species 
in positive blood cultures than the conventional culture-based 
methods in sepsis diagnostics. Clinical sensitivity and speci-
ficity in blood cultures have been high, 95% and 99% (Tissari 
et al. 2010). 
We investigated whether the novel broad-range PCR and 
microarray-based platform efficiently detects bacterial infec-





This was a prospective cohort study of 61 patients with sus-
pected PJI (Table 1). All the patients in a single tertiary care 
hospital in Helsinki who were examined or operated because 
of a suspicion of PJI in their total hip or knee prosthesis and 
who gave their informed consent, and from whom the deep 
samples were successfully obtained, were recruited to this 
study from October 3, 2010 through December 19, 2011. The 
study samples were obtained by needle aspiration (40 sam-
ples for PCR) or during an operation (62 samples for PCR). 
At each operation, the surgeons were asked to take 5 or more 
tissue samples for culture and 2 tissue samples for PCR. The 
29 operations were: 14 prosthesis removals (13 first opera-
tions for 2-stage exchange and 1 girdlestone), three 1-stage 
exchanges, and 12 debridements with implant retention. 
Fever, pain, discharge from the wound, signs of a local infec-
tion, and the presence of a fistula were noted. Blood samples 
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and C-reactive protein (CRP)) were taken and radiographs of 
the affected joint were obtained. Leukocyte count and percent-
age neutrophils were determined from synovial fluid aspirates. 
Data on any previous or ongoing antimicrobial treatment were 
collected.
The control group consisted of 20 patients in whom revision 
hip or knee arthroplasty was performed for aseptic, mechanical 
complications (Table 1). All the patients in the control group 
fulfilled the following criteria: (1) the indication for revision 
was a mechanical complication (liner wear, dislocation) or 
aseptic loosening in a previously well-functioning joint more 
than 5 years after the index operation, (2) CRP below 10 mg/L 
and ESR less than 30 mm/h, and (3) the orthopedic surgeon 
had no suspicion of an infection. All the control samples were 
taken during the operation.
Ethics
Each patient gave written informed consent to participate in 
the study. Ethical committee approval was obtained from our 
hospital district (no. 153/2010).
Definition of infection
The results of the PCR and microarray analysis were com-
pared to the PJI diagnosis defined according to the Musculo-
skeletal Infection Society (MSIS) criteria and to the results of 
bacterial culture (Parvizi et al. 2011).
Based on the MSIS criteria, a diagnosis of PJI is made when 
one or more of the following conditions are met: (1) a sinus 
tract communicating with the prosthesis; or (2) a pathogen 
is isolated by culture from 2 separate tissue or fluid samples 
obtained from the affected prosthetic joint; or (3) 4 of the fol-
lowing 6 criteria exist: (a) elevated serum ESR (> 30 mm/h) or 
CRP concentration (> 10 mg/L), (b) elevated synovial white 
blood cell count, (c) elevated synovial neutrophil percentage, 
(d) presence of purulence in the affected joint, (e) isolation of 
a microorganism in 1 culture of periprosthetic tissue or fluid, 
and (f) greater than 5 neutrophils per high-power field in 5 
high-power fields observed from histological analysis of peri-
prosthetic tissue at 400× magnification. In those cases that did 
not fulfill the MSIS criteria, the appearance of possible signs 
of PJI was evaluated after a follow-up time of 14–28 months. 
PJIs were categorized as (1) early infection (less than 3 
months after surgery), (2) delayed infection (3–24 months 
after surgery), and (3) late infection (more than 24 months 
after surgery) (Zimmerli et al. 2004). 
The bacterial culture was performed according to Clinical 
and Laboratory Standards Institute standards. Aerobic growth 
was performed on non-selective blood agar and chocolate 
agar at 35ºC, in an atmosphere of 5% CO2. Anaerobic growth 
was performed with non-selective Fastidious Anaerobe Agar. 
Thioglycollate broth was used for the enrichment culture. The 
samples were in culture for 7 days and were inspected after 1 
day, 2 days, and 7 days.
Bacterial cultures were regarded as positive if bacterial 
growth was noted from 2 or more tissue samples or synovial 
fluid samples. In cases in which only 1 synovial fluid aspirate 
was taken for microbiological analysis, bacterial growth in 
this aspirate was regarded as a positive result. The PCR and 
microarray result was regarded as positive if bacteria were 
detected in any of the samples.
Samples
All 142 samples in the study were delivered to the investi-
gating laboratory in blind fashion. Sample material included 
bone and other tissue samples, synovial fluid, and pus.
Pretreatment of samples
Bone biopsies, tissue, and viscous pus samples were homog-
enized using the MagNA Lyser instrument and MagNA Lyser 
Green Beads (Roche Applied Science, Germany) according to 
a modification of the manufacturer’s protocol. Each sample 
was transferred to a MagNA Lyser Green Beads tube and 350 
µL of MagNA Pure Bacteria Lysis Buffer (BLB) was added. 
A disruption cycle of 7,000 rpm for 60 sec was performed fol-
lowed by a cooling step, in which the samples were cooled in 
the block at 2–8°C for 90 sec. The steps were repeated 3 times 
and after the final cooling, formed foam was removed by cen-
trifugation at 16,060 × g for 1–3 min. 200 µL of BLB and 20 
µL of PCR-grade proteinase K (14–22 mg/mL; Roche Applied 
Science) was added to the samples.
Bloody synovial fluid and pus samples were diluted by 
adding 1 part of the sample to 9 parts of PCR-grade water 
(Jena Bioscience GmbH, Germany). The samples were incu-
bated for 15 sec at room temperature before centrifugation at 
2,465 × g for 10 min. The pellet was resuspended in 550 µL 
phosphate-buffered saline (PBS) (Jena Bioscience) or PCR-
grade water. 20 µL proteinase K was added to the samples.
Viscous synovial fluid samples (volume > 300 µL) were 
centrifuged at 16,060 × g for 10 min. 100–200 µL of superna-
tant was used to resuspend the pellet. Viscous synovial fluid 
Table 1. Demographic data on 61 patients with suspected pros-
thetic joint infection and 20 negative controls, and on the number 
of samples analyzed
 Study Control p-value
 group group
Samples, n 102 40
Patients   61 20
 Male   30 12 0.5
 Female   31   8 0.5
Mean (SD) age, years   68 (12.8)  69  (8.5)       
Hips (%)   22 (36%) 12 (60%) 0.07
Knees (%)   39 (64%)   8 (40%) 0.07
No. of operations   29 20
Mean (range) no. of 
 PCR-based samples/operation   2.1 (1–4) 2.0
 culture samples/operation   5.6 (3–11) 4.3 (2–6)
 needle aspirations/patient   0.65 (0–2) 0
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samples (volume < 300 µL) were used as such. 20 µL protein-
ase K was added to the samples. 
Non-viscous fluid samples (volume > 550 µL) were centri-
fuged at 16,060 × g for 10 min. The pellet was resuspended 
in 550 µL PBS. Swab samples were dissolved directly in 550 
µL PBS. Sample volumes less than 550 µL were adjusted to 
a final volume of 550 µL using PBS. 20 µL proteinase K was 
added to the samples.
Incubation of samples and DNA extraction 
Pretreated samples were then incubated at 60°C for 2 h with 
agitation at 400 rpm, followed by an incubation at 95°C for 
10 min, after which they were centrifuged at 16,060 × g for 
1 min. 550 µL of each sample was transferred to a NorDiag 
Arrow instrument (NorDiag, Norway). DNA extraction was 
performed with Arrow Viral NA kit v.1.0 or v.2.0 according to 
the manufacturer’s instructions, using 60 µL as elution volume. 
PCR and microarray assay
DNA extracts were analyzed with the Prove-it Bone and 
Joint StripArray assay (research-use-only version; Mobidiag 
Ltd., Helsinki, Finland). The Prove-it Bone and Joint assay 
is a broad-range PCR and microarray-based assay targeting 
over 60 bacterial species (Järvinen et al. 2009, Tissari et al. 
2010, Laakso et al. 2011). Proprietary primers were used for 
amplification of specific regions of the bacterial topoisomer-
ase genes gyrB and parE, and the methicillin-resistance gene 
mecA. 1.5 µL of DNA extract was used as PCR template. The 
PCR procedure was carried out according to the instructions 
of the manufacturer. 
Statistics
Positive predictive value, negative predictive value, false-pos-
itive rate, false-negative rate, and accuracy were calculated. 
Sensitivity, specificity, and confidence intervals (CIs) were 
calculated according to Clinical and Laboratory Standards 
Institute recommendations (National Committee on Clinical 
Laboratory Standards 2002). Fisher’s exact test was used to 
calculate p-values.
Results
Of the 61 suspected PJIs, 38 of them were a PJI according 
to the MSIS criteria. In the PJIs fulfilling the MSIS criteria, 
mean blood leukocyte count was 12.0 × 109/L (range 5–23), 
mean ESR was 56 (19–109) mm/h, and mean CRP was 177 
(15–413) g/L. Mean synovial leukocyte count was 71,090 × 
106/L (1,390–222,000) and mean percentage of polymorpho-
nuclear leukocytes was 89% (46–100). There were 20 early 
infections, 12 delayed infections, and 6 late infections. 
23 suspected PJIs that did not fulfill the MSIS criteria 
showed no new signs of infection during 14–28 months of 
follow-up after the sample collection.
Detection of bacteria from 61 suspected PJIs by PCR 
and microarray assay and by culture 
The PCR and microarray assay was positive in 37 patients and 
29 patients were positive by culture (Tables 2 and 3). In 25 
patients, the same bacteria were identified by microbiological 
culture and by PCR and microarray assay (including 3 cases 
where PCR detected only the methicillin-resistance marker 
gene mecA of staphylococci). Some slightly different poly-
microbial results were obtained in cases with a purulent open 
wound.
Comparison between bacterial detection and the 
MSIS definition 
When compared to the 38 cases with an MSIS clinical defini-
tion of PJI, the study showed 31 true-positive PCR and micro-
array results (Table 4). PCR was positive in 17 of the 20 early 
PJIs, in 8 of the 12 delayed PJIs, and in all 6 late PJIs.
In 5 cases with an MSIS definition of PJI, culture was nega-
tive but PCR detected bacteria (2 Staphylococcus epidermidis, 
1 Staphylococcus aureus, 1 Streptococcus pneumoniae, and 1 
Enterobacter cloacae). All of these patients had received anti-
microbial treatment before sample collection.
Table 2. The results of PCR and microarray assay in 61 patients with 
suspected prosthetic joint infection
Bacteria No. of 
 patients
Prosthetic joint infection fulfilling MSIS criteria (n = 38)
 Staphylococcus aureus 8
 Staphylococcus aureus, mecA 1
 Staphylococcus epidermidis, mecA 4
 MecA 3
 Coagulase-negative staphylococci 2
 Staphylococcus epidermidis 1
 Streptococcus agalactiae 2
 Streptococcus dysgalactiae subspecies equisimilis 2
 Streptococcus pneumoniae 1
 Serratia marcescens 1
 Escherichia coli 1
 Enterobacter cloacae 1
 Staphylococcus aureus, coagulase-negative staphylococci, 
    mecA 1
 Staphylococcus epidermidis, mecA, Enterococcus faecalis 1
 Coagulase-negative staphylococci, Enterococcus faecium 1
 Staphylococcus epidermidis, mecA, Enterococcus faecalis, 
    Enterobacter cloacae 1
 Negative 7
No prosthetic joint infection according to MSIS criteria (n = 23)
 Enterobacteriaceae  3
 Klebsiella pneumoniae and Enterococcus casseliflavus 1
 Acinetobacter baumannii, Klebsiella pneumoniae, and 
    Staphylococcus epidermidis 1
 Staphylococcus epidermidis and mecA 1
 Negative 17
MSIS: the Musculosceletal Infection Society; 
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The effect of ongoing antimicrobial treatment
15 of the 38 PJI patients had ongoing antimicrobial treatment 
when the samples were taken. In these 15 patients, 11 had 
bacteria by PCR and microarray assay and 8 had bacteria by 
microbiological culture (Table 5). In patients with no ongoing 
antimicrobial treatment, the PCR-based assay and culture both 
detected bacteria equally in 20 PJIs that fulfilled the MSIS 
criteria. 
False-positive results
There were 6 false-positive PCR and microarray assay results 
out of 23 real negatives in the PJI suspicion group. All of these 
6 false positives were the only samples from that particular 
patient—single aspirates. In 5 cases, the culture was nega-
tive, MSIS criteria for infection were not met, and no signs 
of infection were noticed in follow-up either. 4 of these false-
positive samples had been analyzed in the laboratory within 
10 days. The PCR and microarray assay results were as fol-
lows: 3 Enterobacteriacae, 1 case with Klebsiella pneumoniae 
and Enterococcus casseliflavus, and 1 case with Acinetobacter 
baumannii, Klebsiella pneumoniae, and Staphylococcus epi-
dermidis. 1 patient was both culture-positive (with very scanty 
growth of Staphylococcus epidermidis from synovial fluid) 
and PCR-positive, but clinically there had been no PJI-fulfill-
ing criteria at the time of sampling; nor was there any evidence 
of PJI during 15 months of follow-up. 
There were 17 true-negative PCR and microarray assay 
results in the PJI-suspicion group. 5 negative PCR and micro-
array assay results matched the finding of negative cultures, 
but there had been a PJI according to the MSIS criteria. 2 of 
these cases had had previous antimicrobial treatment of 10 
days and 16 days. Then there were 2 negative PCR results with 
positive cultures and with the MSIS criteria fulfilled, giving a 
final false-negative rate of 7/28.
Results in the control group
All 40 samples from the 20 controls gave true-negative PCR 
and microarray assay results. All the negative controls were 
also negative by culture.
Sensitivity and specificity
Compared to the MSIS criteria of PJI, the PCR and microar-
ray assay achieved 82% (95% CI: 67–91) sensitivity and 74% 
(95% CI: 54–87) specificity. The predictive value of a positive 
test result was 84% and that of a negative result was 71%. The 
accuracy was 79%. If the detection of only the mecA gene was 
judged to be a false negative, the sensitivity was 74% (95% 
CI: 58–85). 
Discussion 
We found that detection of bacteria by PCR and microarray-
based assay was superior to that by culture in patients who had 
had antimicrobial treatment for more than 4 days. In patients 




Prosthetic joint infection fulfilling MSIS criteria (n = 38)  
 Staphylococcus aureus 8
 Staphylococcus epidermidis 6
 Staphylococcus lugdunensis 3
 Coagulase-negative staphylococci 1
 Streptococcus agalactiae 2
 Group G betahemolytic streptococci a 2
 Serratia marcescens 1
 Escherichia coli 1
 Staphylococcus epidermidis and Enterococcus faecalis 1
 Staphylococcus epidermidis and Streptococcus viridans b  1
 Staphylococcus aureus and Staphylococcus epidermidis  1
 Enterobacter cloacae, Enterococcus faecalis, Citrobacter 1
 Negative 10
No prosthetic joint infection according to MSIS criteria (n = 23)
 Staphylococcus epidermidis  1
 Negative 22
a
 Group G betahemolytic streptococci includes Streptococcus 
   dysgalactiae subspecies equisimilis detected by PCR. 
b
 Streptococcus viridans was not included in the pathogen panel of 
   the PCR assay.
MSIS: The Musculosceletal Infection Society.
Table 4. Results of PCR and microarray 
assay and of culture compared against 
the diagnosis of prosthetic joint infection 
according to the Musculoskeletal Infection 
Society (MSIS) criteria, from 61 patients with 
suspected prosthetic joint infections
 PCR + PCR – Total
MSIS criteria + 31 7 38
 Culture + 26  2 
 Culture – 5 5
MSIS criteria – 6 17 23
 Culture + 1 0 
 Culture – 5 17 
Total 37 24 61
Table 5. Comparison of the effect of previous antimicro bial 
treatment and its length with culture results and PCR and 
microarray assay results from 15 prosthetic joint infections 
fulfilling the Musculoskeletal Infection Society criteria
Length of 
antimicrobial  PCR Culture
treatment + – + –
Up to 3 days 5  1  6  0
4 days or more 6  3  2  7 
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without any ongoing antimicrobial treatment, there was no 
difference between PCR and microarray-based assay and con-
ventional culture in detecting bacteria.
The sensitivity of the PCR and microarray assay was 82%. 
With a broad-range 16S rDNA PCR, Moojen et al. (2007) 
reported a sensitivity of as high as 97%, when compared to 
clinical diagnosis of PJI. More than 90% sensitivity with the 
PCR assay has also been reported by Marin et al. (2012) and 
by Panousis et al. (2005). On the other hand, lower PCR sensi-
tivities in diagnosing PJI have been reported by Fihman et al. 
(2007), at 54%, and by De Man et al. (2009), at 50%. From 
a technical point of view, the PCR and microarray can detect 
only predefined target species, whereas PCR and sequencing 
possibly detects all eubacterial species. However, the ability 
of the microarray to simultaneously detect and identify sev-
eral bacterial species and also antimicrobial resistance genes 
in 1 sample is an advantage over PCR and DNA sequencing, 
where multibacterial infections or multiple targets are tech-
nically challenging. The microarray taxa do not include the 
Streptococcus viridans group, Propionibacter acnes, and 
Mycoplasma or other rare species. This is a limitation of 
the present microarray layout: the next version of the test is 
planned to cover some other important species. On the other 
hand, the gyrB gene used in the Prove-it Bone and Joint assay 
differentiates closely related bacterial species better than 
16S rDNA-based PCR, which is often used with sequencing 
(Dauga 2002, Tayeb et al. 2008). 
The design of the microarray approach tolerates the pres-
ence of traces of environmental DNA, which is often present 
in most reagents and consumables. Nevertheless, the interpre-
tation of results is still difficult if the degree of contamina-
tion is not already known and if meticulous care is not taken 
throughout the process (Bjerkan et al. 2012). For example, 
in this study the false-positive rate for the PCR and microar-
ray assay was 26%, and the possibility of contamination was 
suspected as 4 out of the 6 false positives had been analyzed 
within 10 days, and none of these 6 patients had had any signs 
of PJI during follow-up. Without the 4 false-positive cases—
the suspected cluster of contamination—the specificity of 
the PCR and microarray assay would have been higher: 91% 
(95% CI: 73–98). Thus, positive PCR results must always be 
interpreted with caution if patients do not have clinical signs 
and symptoms of PJI. However, in addition to false positives, 
PCR-based methods may also detect viable but non-cultivable 
(VBNC) bacteria (Trevors 2011).
In our material, the PCR and microarray assay detected the 
smallest proportion of infections in the group of delayed PJIs. 
The delayed infections are usually caused by low-virulence 
organisms such as coagulase-negative staphylococci or Pro-
pionibacterium acnes tightly that are fixed to biofilm on the 
surface of the prosthesis (Zimmerli et al. 2004, Trampuz et 
al. 2007), so they may not always be easily detected with 
PCR methods from periprosthetic tissue biopsies (Ince et al. 
2004). Also, Propionibacterium acnes was not included in the 
pathogen panel of the PCR assay in this study, thus reducing 
the yield in the delayed-PJI group. Sonication of an explanted 
prosthesis to dislodge adherent bacteria followed by sample 
culture has been shown to improve the microbiological diag-
nosis of PJI (Trampuz et al. 2007). PCR after sonication of the 
implant has also been studied, with mostly promising results 
(Achermann et al. 2010, Esteban et al. 2012, Gomez et al. 
2012, Portillo et al. 2012). 
The PCR and microarray assay was more informative 
than culture, if the antimicrobial treatment had already been 
started. Even though the aim should always be to collect 
microbiological samples before initiating antimicrobial treat-
ment (Malekzadeh et al. 2010), the treatment is sometimes ini-
tiated earlier—usually due to severe systemic infection or for 
some other reason. In earlier studies, PCR has also been found 
to be useful in examining samples during antimicrobial treat-
ment (Achermann et al. 2010) and in cultures after sonication 
(Trampuz et al. 2007). 
As in previous studies, the most commonly cultured micro-
organisms in the PJIs were coagulase-negative staphylococci 
and Staphylococcus aureus (Zimmerli et al. 2004, Barberab 
2006). Thus, for the treating physician, detection of the mecA-
resistance gene by PCR is important: it can show whether or 
not vancomycin is needed in the treatment. Also, special rapid 
tests for mecA detection have been developed (Titécat et al. 
2012).
In conclusion, in the present study a PCR and microarray-
based platform—with the attractive possibility of faster bacte-
rial diagnosis than with routine culture—was most helpful in 
PJI diagnostics during ongoing antimicrobial treatment. With-
out any preceding antimicrobial treatment, the assay did not 
appear to provide any additional information to that gained 
from routine culture. 
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